Immunic Appoints Former Genentech Exec Erik Lundgren as CEO
Immunic, Inc (NASDAQ:IMUX) announced it strengthened its leadership team on Wednesday as the company prepares to advance its multiple sclerosis pipeline through late-stage development and potential commercialization. Immunic Appoints Erik Lundgren As CEO Immunic named biop